RxDoctor Payments Data

Lawrence Nguyen, MD

Physical Medicine & Rehabilitation · The Woodlands, TXNPI 1750350567

Payments from drug & device makers

$3,841in general payments, 2019–2025

Across 200 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Collegium Pharmaceutical, Inc.$601
  • Merz Pharmaceuticals, LLC$423
  • Pfizer$170
  • GRT US Holding, Inc.$158
  • Merz North America, Inc.$100
  • plus $657 from 23 others

What the payments were for

  • Food & beverage$3,841100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,841 in reported general payments places this provider in the 90th percentile of 651 physical medicine & rehabilitation providers in Texas.

See all physical medicine & rehabilitation providers in Texas

Medicare billing

Part B allowed, 2024
$513,930
Medicare patients
177
Services billed
26,537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl47$81,284
OzempicSemaglutide59$67,234
Xtampza ErOxycodone Myristate77$48,116
MovantikNaloxegol Oxalate53$27,707
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen779$27,305
Oxycodone Hcl383$12,135
SavellaMilnacipran Hcl11$8,603
Fentanyl80$7,721
BelsomraSuvorexant16$7,144
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen149$5,424
Morphine Sulfate ErMorphine Sulfate125$4,940
Morphine Sulfate106$4,325
Buprenorphine13$4,239
Tizanidine Hcl60$4,011
Gabapentin272$3,702

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$601$48,11677 claims
Redhill Biopharma Inc.Movantik$13$27,70753 claims
AbbVieSavella$1,733$8,60311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 651 physical medicine & rehabilitation providers in Texas.

Other physical medicine & rehabilitation in The Woodlands

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →